Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

354
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
354
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

355
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
355

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initiation of an emergency department discharge pathway for low-risk patients with venous thromboembolism: Factors impact real-world practice.

Vascular medicine (London, England)·2026
Same author

Cumulative Metabolic Exposure to Hyperglycemia and Risk of Cardiovascular and Limb Events in Peripheral Artery Disease.

medRxiv : the preprint server for health sciences·2026
Same author

Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA Trial.

Circulation. Population health and outcomes·2026
Same author

Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease.

Nature communications·2026
Same author

ERBB4 deficiency promotes atrial myopathy underlying the atrial fibrillation substrate.

medRxiv : the preprint server for health sciences·2026
Same author

Validation of Brachial Vein Endothelial Transcriptomics to Assess the Coronary Vasculature.

Circulation research·2026
Same journal

Taphonomic analysis at Liang Bua reveals the behavioral and technological capabilities of <i>Homo floresiensis</i>.

Science advances·2026
Same journal

Targeting granule initiation and amyloplast structure to create giant starch granules in wheat.

Science advances·2026
Same journal

A meta-analysis of carbon losses and gains from tropical moist forest degradation and regeneration.

Science advances·2026
Same journal

Ancient DNA reveals elite dynastic rule among Iron Age Eurasian Steppe nomads.

Science advances·2026
Same journal

Targeting astrocytic Dp71 attenuates BBB disruption after traumatic brain injury through WTAP-associated m<sup>6</sup>A regulation of MMP2.

Science advances·2026
Same journal

Pancreatic α cells are required for nutrient homeostasis by regulating dynamic β cell networks in islets.

Science advances·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
07:14

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

Published on: July 13, 2018

15.1K

Platelets induce endothelial cell mitochondrial dysfunction in myocardial infarction.

Haoyu Sun1, Florencia Schlamp1, Matthew Muller1,2

  • 1Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.

Science Advances
|November 14, 2025
PubMed
Summary
This summary is machine-generated.

Platelets from myocardial infarction (MI) patients cause endothelial mitochondrial dysfunction. C-C motif chemokine ligand 3 (CCL3) released by these platelets is a key mediator, linking platelet activation to coronary endothelial dysfunction in MI.

More Related Videos

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.7K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

989

Related Experiment Videos

Last Updated: Jan 11, 2026

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
07:14

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

Published on: July 13, 2018

15.1K
LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.7K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

989

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Medicine
  • Platelet Physiology

Background:

  • Coronary endothelial dysfunction is central to acute coronary syndromes.
  • Platelets in myocardial infarction (MI) release factors that exacerbate vascular injury.
  • Understanding platelet-endothelial interactions is crucial for treating cardiovascular disease.

Purpose of the Study:

  • To investigate the role of platelet-released factors in endothelial dysfunction following MI.
  • To identify specific mediators involved in platelet-induced endothelial mitochondrial damage.
  • To explore the clinical relevance of identified mediators in cardiovascular disease.

Main Methods:

  • Endothelial cells (ECs) were treated with factors from MI patient platelets.
  • RNA sequencing and mitochondrial function assays (membrane potential, network analysis) were performed.
  • Circulating C-C motif chemokine ligand 3 (CCL3) levels were measured in patients with cardiovascular disease.

Main Results:

  • MI platelets induced significant EC mitochondrial dysfunction.
  • C-C motif chemokine ligand 3 (CCL3) was identified as a key mediator, up-regulated in MI platelets.
  • Blocking the CCL3 receptor, CCR5, reduced its detrimental effects on ECs.
  • Elevated circulating CCL3 levels correlated with major adverse cardiovascular events in patients.

Conclusions:

  • Platelet activation in MI directly contributes to coronary endothelial mitochondrial dysfunction.
  • CCL3 is a critical mediator linking MI platelets to endothelial damage.
  • CCL3 may serve as a biomarker and therapeutic target for cardiovascular events.